Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 10

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 10
---
 Report on Form 10-K for the year ended December 31, 2023, as amended, and in our
other reports filed with the SEC. We advise you to carefully review the reports and documents we file from time to time with the SEC,
particularly our annual reports on Form 10-K, our quarterly reports on Form 10-Q and our current reports on Form 8-K. The
Company cautions readers that the forward-looking statements included in, or incorporated by reference into, this Proxy Statement represent
our beliefs, expectations, estimates and assumptions only as of the date hereof and are not intended to give any assurance as to future
results. New factors emerge from time to time, and it is not possible for us to predict all of these factors. Further, the Company cannot
assess the effect of each such factor on our business or the extent to which any factor, or combination of factors, may cause actual results
to be materially different from those contained in any forward-looking statement.

Readers are cautioned not
to place undue reliance on forward-looking statements because of the risks and uncertainties related to them and to the risk factors.
We disclaim any obligation to update the forward-looking statements contained in, or incorporated by reference into, this Proxy Statement
to reflect any new information or future events or circumstances or otherwise, except as required by the federal securities laws.

<div align='center'>3

IMPORTANT INFORMATION ABOUT THE SPECIAL MEETING AND VOTING</div>

Why is the Company Soliciting My Proxy?

The Board of Directors (the
“Board”) of Petros Pharmaceuticals, Inc. is soliciting your proxy to vote at the 2025 special meeting of stockholders
to be held on Thursday, April 10, 2025, at 10 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/PTPI2025SM,
and any postponement or adjournments of the meeting (the “Special Meeting”). This proxy statement (this “Proxy Statement”)
along with the accompanying Notice of Special Meeting of Stockholders summarizes the purposes of the meeting and the information you need
to know to vote at the Special Meeting.

Who Can Vote?

Only stockholders who owned shares of our common stock, par value $0.0001
per share (the “Common Stock”), or shares of our Series A Convertible Preferred Stock, par value $0.0001 per share (the
“Series A Preferred Stock”), as of the close of business on the Record Date are